... concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta- ... without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized ...

... postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of ... postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of ...

... without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized ... without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized ...

... 5 g/day) increased the risk of esophageal squamous cell carcinoma (RR=1.30 [95% CI, 1.09 to 1.56]), oral cavity and pharynx cancer (RR=1.17 [95% CI, 1.06 ...

... in other parts of the oral cavity , nose, pharynx, larynx (voice box), trachea, or esophagus at the same time. Most oropharyngeal cancers are squamous cell carcinomas . Squamous cells are the thin, flat cells lining ...

... al. Contact endoscopy for the evaluation of the pharyngeal and laryngeal mucosa. Laryngoscope. ... oral squamous cell carcinoma. Oral Oncol. 2010 Apr; 46 (4):226–31. ...

... Morris LG, Ganly I: Outcomes of oral cavity squamous cell carcinoma in pediatric patients. Oral Oncol 46 (4): 292- ... of oral cavity and/or head and neck squamous cell carcinoma include the following:[ 1 - 8 ] Fanconi anemia. Dyskeratosis ...

... patient with Erheim-Chester disease developed a cutaneous squamous cell carcinoma that was treated with surgical excision.[ 48 ] Three ... et al.: Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy. J Am ...